Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126294241 | 12629424 | 1 | I | 20160421 | 20160804 | 20160808 | 20160808 | EXP | AU-MYLANLABS-2016M1032771 | MYLAN | 0.00 | Y | 0.00000 | 20160808 | PH | AU | AU |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126294241 | 12629424 | 1 | PS | EPINEPHRINE. | EPINEPHRINE | 1 | UNK | U | U | 19430 | |||||||||
126294241 | 12629424 | 2 | SS | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | UNK | U | U | 0 | |||||||||
126294241 | 12629424 | 3 | SS | REMIFENTANIL | REMIFENTANIL | 1 | UNK | U | U | 0 | |||||||||
126294241 | 12629424 | 4 | SS | ROCURONIUM | ROCURONIUM BROMIDE | 1 | UNK | U | U | 0 | |||||||||
126294241 | 12629424 | 5 | SS | CEFTRIAXONE. | CEFTRIAXONE | 1 | UNK | U | U | 0 | |||||||||
126294241 | 12629424 | 6 | SS | PROPOFOL. | PROPOFOL | 1 | UNK | U | U | 0 | |||||||||
126294241 | 12629424 | 7 | SS | CHLORHEXIDINE | CHLORHEXIDINE | 1 | UNK | U | U | 0 | |||||||||
126294241 | 12629424 | 8 | SS | METARAMINOL | METARAMINOL | 1 | UNK | U | U | 0 | |||||||||
126294241 | 12629424 | 9 | SS | MORPHINE | MORPHINE | 1 | Intrathecal | UNK | U | U | 0 | ||||||||
126294241 | 12629424 | 10 | SS | ROPIVACAINE HYDROCHLORIDE. | ROPIVACAINE HYDROCHLORIDE | 1 | Intrathecal | UNK | U | U | 0 | ||||||||
126294241 | 12629424 | 11 | SS | LIGNOCAINE /00033401/ | LIDOCAINE HYDROCHLORIDE | 1 | UNK | U | U | 0 | |||||||||
126294241 | 12629424 | 12 | SS | BETADINE | POVIDONE-IODINE | 1 | UNK | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126294241 | 12629424 | 1 | Product used for unknown indication |
126294241 | 12629424 | 2 | Product used for unknown indication |
126294241 | 12629424 | 3 | Product used for unknown indication |
126294241 | 12629424 | 4 | Product used for unknown indication |
126294241 | 12629424 | 5 | Product used for unknown indication |
126294241 | 12629424 | 6 | Product used for unknown indication |
126294241 | 12629424 | 7 | Product used for unknown indication |
126294241 | 12629424 | 8 | Product used for unknown indication |
126294241 | 12629424 | 9 | Product used for unknown indication |
126294241 | 12629424 | 10 | Product used for unknown indication |
126294241 | 12629424 | 11 | Product used for unknown indication |
126294241 | 12629424 | 12 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126294241 | 12629424 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126294241 | 12629424 | Anaphylactic reaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126294241 | 12629424 | 1 | 20160421 | 0 | ||
126294241 | 12629424 | 2 | 20160421 | 0 | ||
126294241 | 12629424 | 3 | 20160421 | 0 | ||
126294241 | 12629424 | 4 | 20160421 | 0 | ||
126294241 | 12629424 | 5 | 20160421 | 0 | ||
126294241 | 12629424 | 6 | 20160421 | 0 | ||
126294241 | 12629424 | 7 | 20160421 | 0 | ||
126294241 | 12629424 | 8 | 20160421 | 0 | ||
126294241 | 12629424 | 9 | 20160421 | 0 | ||
126294241 | 12629424 | 10 | 20160421 | 0 | ||
126294241 | 12629424 | 11 | 20160421 | 0 | ||
126294241 | 12629424 | 12 | 20160421 | 0 |